The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 32.00
Ask: 36.00
Change: 0.00 (0.00%)
Spread: 4.00 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 34.00
SYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - System C Healthcare Plc

11 Mar 2011 07:00

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed: First Eagle Investment Management, LLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: System C Healthcare Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: March 10, 2011
(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:
(2) Derivatives (other than options): 5,500,000 4.73
(3) Options and agreements to purchase/sell:

TOTAL:

5,500,000 4.73

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Derivatives transactions (other than options)

Class of relevant security Product description

e.g. CFD

Nature of dealing Number of reference securities Price per unit
1p ordinary shares CFD Increasing a long position 3,425,000 GBP 0.7011

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: March 10, 2011
Contact name: Hayley Nelson
Telephone number: 212-698-3363

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2011

Date   Source Headline
30th Apr 20247:00 amRNSTrading Update
29th Feb 20248:49 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20247:00 amRNSBoard Change, Update & Change of Registered Office
12th Dec 20234:16 pmRNSBoard Changes
27th Nov 20237:00 amRNSHalf-year Report
1st Nov 20237:00 amRNSTrading Update & Notice of Results
26th Sep 20237:00 amRNSBoard Changes and Change of Adviser
22nd Sep 20232:22 pmRNSResult of AGM
5th Sep 20237:00 amRNSExercise of options and PDMR dealings
17th Aug 20237:00 amRNSNotice of AGM and Availability of ARA
7th Aug 20237:00 amRNSDirector / PDMR dealing
26th Jun 20237:01 amRNSBoard Changes and related party transactions
26th Jun 20237:00 amRNSFinal results for the year ended 31 March 2023
26th May 202312:05 pmRNSExercise of options and director dealing
26th May 20237:00 amRNSBoard Changes
26th Apr 202311:04 amRNSHolding(s) in Company
19th Apr 202310:08 amRNSHolding(s) in Company
18th Apr 20236:00 pmRNSHolding(s) in Company
18th Apr 20237:00 amRNSExec LTIP Awards
18th Apr 20237:00 amRNSHolding(s) in Company
17th Apr 20235:41 pmRNSHolding(s) in Company
17th Apr 20235:37 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
1st Feb 20237:00 amRNSChange of Adviser
31st Jan 20235:49 pmRNSSchedule 2(g) Update
21st Nov 20227:00 amRNSHalf-year Report
3rd Nov 20227:00 amRNSInvestor Presentation
28th Oct 20224:40 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
26th Oct 20227:00 amRNSTrading Update
10th Oct 20225:28 pmRNSHolding(s) in Company
8th Sep 20221:12 pmRNSResult of AGM
28th Jul 202211:09 amRNSNotice of AGM & Availability of Annual Report
22nd Jun 20227:00 amRNSExecutive LTIP Awards
20th Jun 20227:00 amRNSFinal Results
8th Jun 202212:22 pmRNSInvestor Presentation
27th Apr 20227:00 amRNSAcquisition of Independent Network Solutions Ltd
19th Apr 20227:00 amRNSTrading Update and Notice of Results
5th Apr 20227:00 amRNSAcquisition of Truststream Security Solutions Ltd
4th Apr 20227:00 amRNSChange of Adviser
1st Apr 20225:05 pmRNSSchedule 2(g) update
22nd Nov 20217:00 amRNSHalf-year Report
8th Nov 202111:59 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSInvestor Presentation
29th Oct 20219:05 amRNSSecond Price Monitoring Extn
29th Oct 20219:00 amRNSPrice Monitoring Extension
29th Oct 20217:00 amRNSTrading Update and Notice of Results
16th Sep 202111:21 amRNSResult of AGM
23rd Aug 20217:00 amRNSNotice of AGM and Annual Report 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.